Abstrakt

Przypisy

• 1. Balasubramaniyan V., Boddeke E., Bakels R., Küst B., Kooistra S.,Veneman A., Copray S.: Effects of histone deacetylation inhibitionon neuronal differentiation of embryonic mouse neural stem cells.Neuroscience, 2006; 143: 939-951
  Google Scholar
• 2. Blaheta R.A., Cinatl J. Jr.: Anti-tumor mechanisms of valproate: anovel role for an old drug. Med. Res. Rev., 2002; 22: 492-511
  Google Scholar
• 3. Borkowska P., Fila-Danilow A., Paul-Samojedny M., KowalczykM., Hart J., Ryszawy J., Kowalski J.: Differentiation of adult rat mesenchymalstem cells to GABAergic, dopaminergic and cholinergicneurons. Pharmacol. Rep., 2015; 67: 179-186
  Google Scholar
• 4. Conway G.D., O’Bara M.A., Vedia B.H., Pol S.U., Sim F.J.: Histonedeacetylase activity is required for human oligodendrocyte progenitordifferentiation. Glia, 2012; 60: 1944-1953
  Google Scholar
• 5. Coyle J.T., Duman R.S.: Finding the intracellular signaling pathwaysaffected by mood disorder treatments. Neuron, 2003; 38:157-160
  Google Scholar
• 6. Foti S.B., Chou A., Moll A.D., Roskams A.J.: HDAC inhibitors dysregulateneural stem cell activity in the postnatal mouse brain. Int.J. Dev. Neurosci., 2013; 31: 434-447
  Google Scholar
• 7. Gray S.G., Ekström T.J.: The human histone deacetylase family.Exp. Cell Res., 2001; 262: 75-83
  Google Scholar
• 8. Grunstein M.: Histone acetylation in chromatin structure andtranscription. Nature, 1997; 389: 349-352
  Google Scholar
• 9. Haberland M., Montgomery R.L., Olson E.N.: The many roles ofhistone deacetylases in development and physiology: implicationsfor disease and therapy. Nature Rev. Genet., 2009; 10: 32-42
  Google Scholar
• 10. Hsieh J., Aimone J.B., Kaspar B.K., Kuwabara T., Nakashima K.,Gage F.H.: IGF-I instructs multipotent adult neural progenitor cellsto become oligodendrocytes. J. Cell Biol., 2004; 164: 111-122
  Google Scholar
• 11. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H.: Histonedeacetylase inhibition-mediated neuronal differentiation of multipotentadult neural progenitor cells. Proc. Natl. Acad. Sci. USA,2004; 101: 16659-16664
  Google Scholar
• 12. Huangfu D., Maehr R., Guo W., Eijkelenboom A., Snitow M., ChenA.E., Melton D.A.: Induction of pluripotent stem cells by definedfactors is greatly improved by small-molecule compounds. Nat. Biotechnol.,2008; 26: 795-797
  Google Scholar
• 13. Kawamura T., Ono K., Morimoto T., Wada H., Hirai M., HidakaK., Morisaki T., Heike T., Nakahata T., Kita T., Hasegawa K.: Acetylationof GATA-4 is involved in the differentiation of embryonic stemcells into cardiac myocytes. J. Biol. Chem., 2005; 280: 19682-19688
  Google Scholar
• 14. Kim H.S., Park J.S., Hong S.J., Woo M.S., Kim S.Y., Kim K.S.: Regulationof the tyrosine hydroxylase gene promoter by histone deacetylaseinhibitors. Biochem. Biophys. Res. Commun., 2003; 312: 950-957
  Google Scholar
• 15. Kouzarides T.: Acetylation: a regulatory modification to rivalphosphorylation? EMBO J., 2000; 19: 1176-1179
  Google Scholar
• 16. Laeng P., Pitts R.L., Lemire A.L., Drabik C.E., Weiner A., Tang H.,Thyagarajan R., Mallon B.S., Altar C.A.: The mood stabilizer valproicacid stimulates GABA neurogenesis from rat forebrain stem cells. J.Neurochem., 2004; 91: 238-251
  Google Scholar
• 17. Livak K.J., Schmittgen T.D.: Analysis of relative gene expressiondata using real-time quantitative PCR and the 2-DDCt method. Methods,2001; 25: 402-408
  Google Scholar
• 18. Marin-Husstege M., Muggironi M., Liu A., Casaccia-Bonnefil P.:Histone deacetylase activity is necessary for oligodendrocyte lineageprogression. J. Neurosci., 2002; 22: 10333-10345
  Google Scholar
• 19. Pérez M., Rojo A.I., Wandosell F., Diaz-Nido J., Avila J.: Prionpeptide induces neuronal cell death through a pathway involvingglycogen synthase kinase 3. Biochem. J., 2003; 372: 129-136
  Google Scholar
• 20. Polevoda B., Sherman F.: The diversity of acetylated proteins.Genome Biol., 2002; 3: reviews 0006
  Google Scholar
• 21. Rössler R., Boddeke E., Copray S.: Differentiation of non-mesencephalicneural stem cells towards dopaminergic neurons. Neuroscience,2010; 170: 417-428
  Google Scholar
• 22. Shen S., Sandoval J., Swiss V.A., Li J., Dupree J., Franklin R.J.,Casaccia-Bonnefil P.: Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat. Neurosci., 2008; 11: 1024-1034
  Google Scholar
• 23. Siebzehnrubl F.A., Buslei R., Eyupoglu I.Y., Seufert S., HahnenE., Blumcke I.: Histone deacetylase inhibitors increase neuronaldifferentiation in adult forebrain precursor cells. Exp. Brain Res.2007; 176: 672-678
  Google Scholar
• 24. Sun G., Fu C., Shen C., Shi Y.: Histone deacetylases in neuralstem cells and induced pluripotent stem cells. J. Biomed. Biotechnol.,2011; 2011: 835968
  Google Scholar
• 25. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B.: Adult ratand human bone marrow stromal cells differentiate into neurons.J. Neurosci. Res., 2000; 61: 364-370
  Google Scholar
• 26. Ye F., Chen Y., Hoang T., Montgomery R.L., Zhao X.H., Bu H., HuT., Taketo M.M., van Es J.H., Clevers H., Clevers H., Hsieh J., Bassel–Duby R., Olson E.N., Lu Q.R.: HDAC1 and HDAC2 regulate oligodendrocytedifferentiation by disrupting the β-catenin-TCF interaction.Nat. Neurosci., 2009; 12: 829-838
  Google Scholar

Pełna treść artykułu